Bell Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bell Investment Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$599	–	1876
2026 Q1	$599	Buy	+3	New	+$594	﹤0.01%	1682
2021 Q4	–	Sell	-6	Closed	-$1K	–	1875
2021 Q3	$1K	Buy	+6	New	+$464	﹤0.01%	1448

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bell Investment Advisors's LGND Position: Q2 2026 in Review

Bell Investment Advisors sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 3 shares — an estimated $599 sold.

Bell Investment Advisors first reported a position in LGND in Q3 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Bell Investment Advisors reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Bell Investment Advisors sold 3 Ligand Pharmaceuticals shares in Q2 2026, an estimated $599.
Bell Investment Advisors first reported a position in Ligand Pharmaceuticals in Q3 2021 and held it in 2 quarters.
Bell Investment Advisors's Ligand Pharmaceuticals position peaked at $1K in Q3 2021.
414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.